Orchid Pharma Announcements
Confirmation certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations, 2018 for the Quarter- IV ended on March 31, 2026 of FY 2025-26.
09 Apr, 2026 | 12:18pm • Source: BSE
Intimation of Roadshow scheduled to be held on April 10, 2026.
07 Apr, 2026 | 06:19pm • Source: BSE
Update on credit rating of Orchid Pharma Limited
02 Apr, 2026 | 03:51pm • Source: BSE
Intimation of Trading Window Closure for Quarter IV for the Financial Year 2025-26, ending on March 31, 2026
27 Mar, 2026 | 05:42pm • Source: BSE
Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited (''Amalgamating Company'') with Orchid Pharma Limited (''Amalgamated Company'') and their respective shareholders and creditors...
18 Mar, 2026 | 09:17pm • Source: BSE
Transcript of Analysts/ Investors Earning call held with Public at large on February 12, 2026, through tele-conferencing.
16 Feb, 2026 | 05:57pm • Source: BSE
Intimation of schedule of Analysts/ Investors Earning Call, ratifying the inadvertent display error in earlier communication, scheduling the meet for the quarter III of financial...
06 Feb, 2026 | 04:08pm • Source: BSE
Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-III of F.Y. 2025-26 ended on December 31, 2025.
06 Feb, 2026 | 03:26pm • Source: BSE
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...
06 Feb, 2026 | 02:37pm • Source: BSE
Compliance certificate under regulation 74(5) of SEBI (Depositories and participants) Regulations for the Quarter-III of F.Y. 2025-26 ended on December 31, 2025.
08 Jan, 2026 | 04:33pm • Source: BSE
Intimation of Trading Window Closure for the Quarter III of Financial Year 2025-26, ending on December 31, 2025
29 Dec, 2025 | 06:15pm • Source: BSE
Transcript of Analysts/ Investors Earning call held with public at large on November 11, 2025 for the quarter ended September 2025
17 Nov, 2025 | 04:05pm • Source: BSE
Audio Recording of the Analysts/Earnings call for the Financial Results of the Company for the Q-2 & Half year ended on September 30, 2025.
11 Nov, 2025 | 07:23pm • Source: BSE
Investor Presentation for the Analysts/Investors Earnings Call for the Q-2 & Half Year for F.Y.2025-26, ended on September 30, 2025.
11 Nov, 2025 | 03:37pm • Source: BSE
Unaudited Limited Reviewed Financial Results for the Q-2 & Half Year ended on September 30, 2025
11 Nov, 2025 | 03:28pm • Source: BSE
Outcome of Board Meeting- Q2- F.Y.2025-26
11 Nov, 2025 | 03:21pm • Source: BSE
Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-II of F.Y. 2025-26 ended on September 30, 2025
05 Nov, 2025 | 02:47pm • Source: BSE
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and...
05 Nov, 2025 | 12:20pm • Source: BSE
Significant increase in volume has been observed in Orchid Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the...
04 Nov, 2025 | 03:09pm • Source: NSE
Orchid Pharma Limited''s response on the spurt in volume of security across stock exchanges.
04 Nov, 2025 | 12:36pm • Source: BSE